Canadian Court Blocks Generic Celebrex Launch
A Canadian appeals court has upheld patents for painkiller Celebrex that prevent the launch of a generic version of the drug until November 2014, Pfizer Inc. said Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article